Jennifer Wang
Amgen (United States)(US)University of Illinois Chicago(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Hepatocellular Carcinoma Treatment and Prognosis, Healthcare Systems and Technology, Hepatitis C virus research, Liver Disease and Transplantation
Most-Cited Works
- → Hepatotoxicity From Immune Checkpoint Inhibitors: A Systematic Review and Management Recommendation(2020)252 cited
- → Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy(2022)108 cited
- → Liver transplantation for alcoholic hepatitis in the United States: Excellent outcomes with profound temporal and geographic variation in frequency(2020)102 cited
- → Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes(2021)59 cited
- → Epstein-Barr Virus (EBV)-Encoded RNA: Automated In-Situ Hybridization (ISH) Compared with Manual ISH and Immunohistochemistry for Detection of EBV in Pediatric Lymphoproliferative Disorders(2008)44 cited
- → Simultaneous Heart–Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes(2020)35 cited
- → Durable responses in patients with genitourinary cancers following immune checkpoint therapy rechallenge after moderate-to-severe immune-related adverse events(2021)25 cited
- → “Raising HOPE”: Improved Outcomes for HIV/HCV-coinfected Liver Transplant Recipients in the Direct-acting Antiviral Era(2021)12 cited
- → Systemic Therapy for Hepatocellular Carcinoma(2021)7 cited
- → Electronic Consultations to Hepatologists Reduce Wait Time for Visits, Improve Communication, and Result in Cost Savings(2019)4 cited